Graft Versus Host Disease-Reduction Strategies
A Phase II Randomized Controlled Trial Comparing GVHD-Reduction Strategies for Allogeneic Peripheral Blood Transplantation (PBSCT) for Patients With Acute Leukemia or Myelodysplastic Syndrome: Selective Depletion of CD45RA+ Naïve T Cells (TND) vs. Post-Transplantation Cyclophosphamide (PTCy)
Arms / Cohorts
Experimental, Arm A1:Total Body Irradiation Based
Accepting patients
Experimental, Arm A2:Busulfan Based
Accepting patients
Experimental, Arm C1:TBI, PTCy, tacrolimus)
Accepting patients
Experimental, Arm C2:Busulfan, PTCy, tacrolimus)
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.